Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-19-000013
Filing Date
2019-01-09
Accepted
2019-01-08 17:59:38
Documents
33
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q devv_10q.htm 10-Q 194847
2 CERTIFICATION devv_ex311.htm EX-31.1 7439
3 CERTIFICATION devv_ex321.htm EX-32.1 3309
  Complete submission text file 0001640334-19-000013.txt   1045315

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT devv-20180930.xml EX-101.INS 94114
5 XBRL TAXONOMY EXTENSION SCHEMA devv-20180930.xsd EX-101.SCH 16499
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE devv-20180930_cal.xml EX-101.CAL 25888
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE devv-20180930_def.xml EX-101.DEF 37413
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE devv-20180930_lab.xml EX-101.LAB 101743
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE devv-20180930_pre.xml EX-101.PRE 85296
Mailing Address 500 NORTH MICHIGAN AVENUE #600 CHICAGO IL 89015
Business Address 500 NORTH MICHIGAN AVENUE #600 CHICAGO IL 89015 (773) 236-8132
BIOSCIENCE NEUTRACEUTICALS, INC. (Filer) CIK: 0001555995 (see all company filings)

EIN.: 460745348 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36604 | Film No.: 19516884
SIC: 5900 Retail-Miscellaneous Retail